These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8679789)

  • 1. Plasma homovanillic acid concentrations in catatonia.
    Northoff G; Demisch L; Wenke J; Pflug B
    Biol Psychiatry; 1996 Mar; 39(6):436-43. PubMed ID: 8679789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catatonia: short-term response to lorazepam and dopaminergic metabolism.
    Northoff G; Wenke J; Demisch L; Eckert J; Gille B; Pflug B
    Psychopharmacology (Berl); 1995 Nov; 122(2):182-6. PubMed ID: 8848534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms.
    Northoff G; Koch A; Wenke J; Eckert J; Böker H; Pflug B; Bogerts B
    Mov Disord; 1999 May; 14(3):404-16. PubMed ID: 10348462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.
    Pickar D; Breier A; Kelsoe J
    Ann N Y Acad Sci; 1988; 537():339-46. PubMed ID: 2904783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ball experiments in 32 acute akinetic catatonic patients: deficits of internal initiation and generation of movements.
    Northoff G; Wenke J; Krill W; Pflug B
    Mov Disord; 1995 Sep; 10(5):589-95. PubMed ID: 8552110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of coagulation marker fibrin D-dimer in early diagnosis of catatonia.
    Haouzir S; Lemoine X; Desbordes M; Follet M; Meunier C; Baarir Z; Allio G; Menard JF; Briant L; Jouen F; Petit M
    Psychiatry Res; 2009 Jun; 168(1):78-85. PubMed ID: 19447502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on a time-dependent model of neuroleptic action.
    Pickar D
    Schizophr Bull; 1988; 14(2):255-68. PubMed ID: 2904694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
    Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
    Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume.
    Breier A; Davis OR; Buchanan RW; Moricle LA; Munson RC
    Arch Gen Psychiatry; 1993 Jul; 50(7):541-50. PubMed ID: 8317948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Catatonia: resurgence of a concept. A review of the international literature].
    Pommepuy N; Januel D
    Encephale; 2002; 28(6 Pt 1):481-92. PubMed ID: 12506260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication.
    Peralta V; Campos MS; de Jalon EG; Cuesta MJ
    Schizophr Res; 2010 May; 118(1-3):168-75. PubMed ID: 20071147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):462-8. PubMed ID: 17188791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects.
    Wei J; Ramchand CN; Hemmings GP
    Schizophr Res; 1992 Dec; 8(2):103-10. PubMed ID: 1360811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal changes in symptoms and plasma homovanillic acid levels in chronically medicated schizophrenic patients.
    Suzuki E; Kanba S; Nibuya M; Adachi S; Sekiya U; Shintani F; Kinoshita N; Yagi G; Asai M
    Biol Psychiatry; 1994 Nov; 36(10):654-61. PubMed ID: 7880934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report.
    Ohi K; Kuwata A; Shimada T; Yasuyama T; Nitta Y; Uehara T; Kawasaki Y
    Medicine (Baltimore); 2017 Apr; 96(16):e6566. PubMed ID: 28422845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL
    Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D; Labarca R; Doran AR; Wolkowitz OM; Roy A; Breier A; Linnoila M; Paul SM
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.